These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1974706

  • 1. Intracerebroventricular infusion but not bolus injection of vasopressin increases the cerebrospinal fluid pressure in awake rabbits.
    Sørensen PS, Gyring JA.
    Neurol Res; 1990 Jun; 12(2):83-8. PubMed ID: 1974706
    [Abstract] [Full Text] [Related]

  • 2. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats.
    Seckl JR, Lightman SL.
    Brain Res; 1987 Oct 13; 423(1-2):279-85. PubMed ID: 3676810
    [Abstract] [Full Text] [Related]

  • 3. Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.
    Seckl JR, Lightman SL.
    Exp Brain Res; 1991 Oct 13; 84(1):173-6. PubMed ID: 1855557
    [Abstract] [Full Text] [Related]

  • 4. The effects of intracerebroventricular versus intravenous administration of vasopressin on intracranial pressure in the rat.
    Saladin LK, Bruni JE.
    Neurol Res; 1993 Jun 13; 15(3):198-203. PubMed ID: 8103586
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid pressure during cerebroventricular infusion of angiotensin and vasopressin.
    Barbella YR, Keil LC, Wurpel JN, Severs WB.
    Exp Neurol; 1983 Nov 13; 82(2):325-34. PubMed ID: 6628620
    [Abstract] [Full Text] [Related]

  • 6. Central losartan blocks natriuretic, vasopressin, and pressor responses to central hypertonic NaCl in sheep.
    Mathai ML, Evered MD, McKinley MJ.
    Am J Physiol; 1998 Aug 13; 275(2):R548-54. PubMed ID: 9688692
    [Abstract] [Full Text] [Related]

  • 7. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
    Sweep CG, Boomkamp MD, Barna I, Logtenberg AW, Wiegant VM.
    Acta Endocrinol (Copenh); 1990 Feb 13; 122(2):191-200. PubMed ID: 2138399
    [Abstract] [Full Text] [Related]

  • 8. Interaction of changes in the third ventricular CSF tonicity, central and systemic AVP concentrations and water intake.
    Eriksson S, Simon-Oppermann C, Simon E, Gray DA.
    Acta Physiol Scand; 1987 Aug 13; 130(4):575-83. PubMed ID: 3630735
    [Abstract] [Full Text] [Related]

  • 9. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF, Dantzer R, Bluthé RM, Lebrun C, Bloom FE, Le Moal M.
    Peptides; 1986 Aug 13; 7(2):213-8. PubMed ID: 3737445
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
    Arnauld E, Bibene V, Meynard J, Rodriguez F, Vincent JD.
    Am J Physiol; 1989 Mar 13; 256(3 Pt 2):R674-84. PubMed ID: 2923256
    [Abstract] [Full Text] [Related]

  • 11. Effect of arginine vasopressin, acetazolamide, and angiotensin II on CSF pressure at simulated altitude.
    Senay LC, Tolbert DL.
    Aviat Space Environ Med; 1984 May 13; 55(5):370-6. PubMed ID: 6732691
    [Abstract] [Full Text] [Related]

  • 12. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
    Iitake K, Kimura T, Ota K, Shoji M, Inoue M, Ohta M, Sato K, Yamamoto T, Yasujima M, Abe K.
    Am J Physiol; 1989 Oct 13; 257(4 Pt 1):E611-6. PubMed ID: 2529777
    [Abstract] [Full Text] [Related]

  • 13. Reflex effect of vasopressin after blockade of V1 receptors in the area postrema.
    Hasser EM, Bishop VS.
    Circ Res; 1990 Aug 13; 67(2):265-71. PubMed ID: 2376071
    [Abstract] [Full Text] [Related]

  • 14. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
    Maione S, Vitagliano S, Berrino L, Lampa E, Rossi F.
    Neuropharmacology; 1992 Apr 13; 31(4):403-7. PubMed ID: 1355901
    [Abstract] [Full Text] [Related]

  • 15. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
    Harland D, Gardiner SM, Bennett T.
    Circ Res; 1989 Oct 13; 65(4):925-33. PubMed ID: 2791228
    [Abstract] [Full Text] [Related]

  • 16. Changes in amino acid levels in rat plasma, cisternal cerebrospinal fluid, and brain tissue induced by intravenously infused arginine-vasopressin.
    Reichel A, Begley DJ, Ermisch A.
    Peptides; 1995 Oct 13; 16(5):965-71. PubMed ID: 7479343
    [Abstract] [Full Text] [Related]

  • 17. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate behavioral effects of interleukin-1 in rat.
    Bluthé RM, Dantzer R.
    Brain Res Bull; 1992 Dec 13; 29(6):897-900. PubMed ID: 1473021
    [Abstract] [Full Text] [Related]

  • 18. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A, Knigge U, Olsen L, Vilhardt H, Warberg J.
    Endocrinology; 1991 Jan 13; 128(1):103-10. PubMed ID: 1986913
    [Abstract] [Full Text] [Related]

  • 19. Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone.
    Tilbrook AJ, Canny BJ, Stewart BJ, Serapiglia MD, Clarke IJ.
    J Endocrinol; 1999 Aug 13; 162(2):301-11. PubMed ID: 10425469
    [Abstract] [Full Text] [Related]

  • 20. Central nervous system mechanisms involved in inhibition of renal sympathetic nerve activity induced by arginine vasopressin.
    Suzuki S, Takeshita A, Imaizumi T, Hirooka Y, Yoshida M, Ando S, Nakamura M.
    Circ Res; 1989 Nov 13; 65(5):1390-9. PubMed ID: 2805250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.